hit counter
AbbVie Inc. (ABBV) Stock News Sentiment & Price - Sentifly
ABBV - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



AbbVie Inc. (ABBV)

USA
Drug Manufacturers - Major
NYSE
ABBV Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ABBV Latest news
Seeking Alpha
Positive
Dividend Harvesting: Week 36 Update, $3,600 Allocated, $239.30 In Annual Dividends Yielding 6.54% With 52 Positions
2021-11-11 08:30

After 36 weeks and $3,600, the Dividend Harvesting Portfolio is generating $239.30 in estimated annual income and $19.94 in monthly estimated income.

Seeking Alpha
Positive
Dividend Increases: October 23-29, 2021
2021-11-10 10:25

In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.

PRNewsWire
Neutral
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025
2021-11-10 08:30

NORTH CHICAGO, Ill. and CHICAGO, Nov. 10, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research.

PRNewsWire
Neutral
AbbVie to Present at the Wolfe Research Healthcare Conference
2021-11-10 08:00

NORTH CHICAGO, Ill., Nov. 10, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Wednesday, November 17, 2021.

Seeking Alpha
Neutral
Dividend Income Summary: Bert's October 2021 Report
2021-11-09 15:22

Dividend Income Summary: Bert's October 2021 Report

PRNewsWire
Neutral
AbbVie Presents New Efficacy Data on Upadacitinib (RINVOQ®) in People with Active Psoriatic Arthritis and Axial Involvement at ACR Convergence 2021
2021-11-09 08:45

NORTH CHICAGO, Ill., Nov. 9, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced results from new post-hoc analyses from the Phase 3 SELECT-PsA 1 and SELECT-PsA 2 trials assessing the efficacy of upadacitinib (RINVOQ®) on axial symptoms in adult patients with active psoriatic arthritis (PsA) and axial involvement.

PRNewsWire
Neutral
AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ® (Upadacitinib) Among Patients with Rheumatoid Arthritis
2021-11-09 08:31

NORTH CHICAGO, Ill., Nov. 9, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new results from a post-hoc analysis of the Phase 3 SELECT-BEYOND clinical trial evaluating RINVOQ® (upadacitinib; 15 mg, once daily) in patients with moderate to severe rheumatoid arthritis (RA) on stable background of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) with prior inadequate response or intolerance to at least one biologic DMARD.

PRNewsWire
Neutral
Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the AAO (American Academy of Ophthalmology) 2021 Annual Meeting
2021-11-08 08:30

NORTH CHICAGO, Ill., Nov. 8, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new pooled post-hoc analyses and patient-reported outcomes (PROs) of VUITYTM (pilocarpine HCl ophthalmic solution) 1.25%, newly approved by the FDA as the first and only eye drop to treat presbyopia; additional analyses on DURYSTA® (bimatoprost intracameral implant); and three real-world data studies on the glaucoma patient journey at the AAO (American Academy of Ophthalmology) 2021 Annual Meeting, November 12-15.

The Motley Fool
Positive
3 Best Biotech Stocks to Buy in November
2021-11-08 07:15

These companies could both diversify your portfolio and boost your dividend income.

Seeking Alpha
Positive
The Near-Perfect Portfolio For The Good Times And Bad
2021-11-06 09:00

No portfolio or strategy can be perfect. But can there be a strategy that can work well in a bull market, a bear market, or a stagnant market, generate a decent income, and conserve capital, all at the same time? We also want our strategy to avoid roller-coaster rides of index investing, have low volatility and limited drawdowns in case of deep corrections.

Loading more news...